MG

Manjula Gubala

Active Director Designated Partner DIN 10629105
DIN 10629105 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Manjula Gubala

Data last updated:

Manjula Gubala is a Designated Partner at Vision Win Life Sciences Llp (since 2024).

DIN 10629105
Primary Designation Designated Partner
First Appointment 15 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 May 20242024Active

Board colleagues of Manjula Gubala

NameDINCompanyDesignation
Battina Sailaja10629102Vision Win Life Sciences LlpDesignated Partner
Gandham Haritha10629103Vision Win Life Sciences LlpDesignated Partner
Goobala Venugopal10629104Vision Win Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vision Win Life Sciences Llp
Premium access

Shareholding and investment profile for Manjula Gubala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjula Gubala

Manjula Gubala currently holds 1 directorship: Vision Win Life Sciences Llp (Designated Partner, since 15 May 2024).

Manjula Gubala was first appointed on 15 May 2024 as Designated Partner at Vision Win Life Sciences Llp.

The current boards of Manjula Gubala's companies include Battina Sailaja (Vision Win Life Sciences Llp), Gandham Haritha (Vision Win Life Sciences Llp), Goobala Venugopal (Vision Win Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available